Screener
Wave Life Sciences WVE Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Restricted cash | 3,815 | 3,806 |
| Other assets | 667 | 16 |
| Total long-term assets | 50,813 | 23,685 |
| Total assets | $558,321 | $638,499 |
| Liabilities, Series A preferred shares, and shareholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $20,362 | $15,700 |
| Accrued expenses and other current liabilities | 18,242 | 26,564 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's total assets?
- Wave Life Sciences (WVE) reported total assets of $558.32M in Q2 2026.
- How has Wave Life Sciences's total assets changed year-over-year?
- Wave Life Sciences's total assets increased by 121.2% year-over-year, from $252.36M to $558.32M.
- What is the long-term trend for Wave Life Sciences's total assets?
- Over 5 years (2020 to 2025), Wave Life Sciences's total assets has grown at a 18.0% compound annual growth rate (CAGR), from $279.24M to $638.5M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Wave Life Sciences's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude